Archives

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
Randstad Digital Named Workday Deployment Partner, Bringing Global Scale and Domain Expertise to Enterprise Clients
Market Updates

Randstad Digital Named Workday Deployment Partner, Bringing Global Scale and Domain Expertise to Enterprise Clients

DIEMEN, Netherlands, July 8, 2025 /PRNewswire/ -- Randstad Digital, a trusted Partner for Talent specializing in digital talent and solutions, today announced it has signed a partnership agreement wit...

  • July 08, 2025 05:00 AM PDT
  • EODHD
Bob and Brad Debuts Exclusive Pain Management Line at Walmart
Market Updates

Bob and Brad Debuts Exclusive Pain Management Line at Walmart

New Product Line Unveils Innovative, Drug-Free Solutions Transforming the Pain Management Aisle At Walmart WINONA, Minn. , July 8, 2025 /PRNewswire/ -- Bob and Brad, the globally recognized physical t...

  • July 08, 2025 05:00 AM PDT
  • EODHD
Akebia Therapeutics to Present at the H.C. Wainwright 4th Annual Kidney Virtual Conference
Market Updates

Akebia Therapeutics to Present at the H.C. Wainwright 4th Annual Kidney Virtual Conference

CAMBRIDGE, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, to...

  • July 08, 2025 05:00 AM PDT
  • EODHD
Abbott's Latest-Generation FreeStyle Libre 3 Plus Glucose Sensor Technology Launches in Canada
Market Updates

Abbott's Latest-Generation FreeStyle Libre 3 Plus Glucose Sensor Technology Launches in Canada

Abbott continues to transform diabetes care with its leading Libre systems and the new FreeStyle Libre 3 Plus* sensor MISSISSAUGA, ON, July 8, 2025 /CNW/ -- Abbott (NYSE: ABT) today announced that its...

  • July 08, 2025 05:00 AM PDT
  • EODHD
How Japan’s trillion-dollar bet on Donald Trump ended with 25% tariffs
Economy

How Japan’s trillion-dollar bet on Donald Trump ended with 25% tariffs

Earlier this year, Japanese Prime Minister Shigeru Ishiba traveled to Washington with a bold offer. He was aware about President Donald Trump’s frustration over the imbalance in US-Japan trade relations and offered to boost Japan’s cumulative investment in the United States to $1 trillion. It was more than a symbolic move as Japan is already […]

  • July 08, 2025 04:57 AM PDT
  • Invezz
Reddit stock price target raised to $151 from $120 at Baird
Market Updates

Reddit stock price target raised to $151 from $120 at Baird

Investing.com - Baird raised its price target on Reddit (NYSE:RDDT) to $151.00 from $120.00 on Tuesday, while maintaining a Neutral rating on the stock. The social media platform, currently trading at...

  • July 08, 2025 04:56 AM PDT
  • EODHD
Meta Poaches Top AI Talent From Apple
Market Updates

Meta Poaches Top AI Talent From Apple

Meta is hiring away top AI talent from Apple. Matthew Bloxham of Bloomberg Intelligence is on "Bloomberg Brief." View Comments

  • July 08, 2025 04:51 AM PDT
  • EODHD
Bitdu issues official statement: ‘Bitdu Pro App’ identified as fraudulent, unaffiliated
Press Release

Bitdu issues official statement: ‘Bitdu Pro App’ identified as fraudulent, unaffiliated

Leading global digital asset exchange Bitdu has issued an official clarification regarding the emergence of a deceptive application titled “Bitdu Pro App”, which falsely claims to represent the Bitdu platform. Based on user complaints and internal investigations, the app has been identified as a fraudulent third-party tool involved in scam activities that include withholding user […]

  • July 08, 2025 04:47 AM PDT
  • Invezz
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Market Updates

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, July 08, 2025--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today anno...

  • July 08, 2025 04:30 AM PDT
  • EODHD
Upstream Bio begins phase 2 COPD trial for verekitug
Market Updates

Upstream Bio begins phase 2 COPD trial for verekitug

WALTHAM, Mass. - Upstream Bio, Inc. (NASDAQ:UPB) has dosed the first patient in its Phase 2 clinical trial evaluating verekitug for chronic obstructive pulmonary disease (COPD), the company announced...

  • July 08, 2025 04:21 AM PDT
  • EODHD
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.